Folliculin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Full Name: Folliculin
Chromosomal Location: 17p11.2
NCBI Gene ID: 201163
Ensembl ID: ENSG00000154803
UniProt: Q8IVP8
Aliases: FLCN, BHD, MIM 607273
FLCN encodes folliculin, a tumor suppressor protein that functions as a regulator of the AMPK and mTOR signaling pathways. Originally identified as the causative gene for Birt-Hogg-Dubé syndrome (a hereditary cancer syndrome), FLCN plays important roles in cellular energy metabolism, lysosomal function, and metabolic stress responses. Recent research reveals that FLCN dysfunction may contribute to neurodegenerative processes through its interactions with the mTORC1 pathway and metabolic regulation.
The FLCN gene consists of:
- 14 exons spanning approximately 32 kb
- Single transcript encoding 579 amino acids
- Conserved across mammals
Folliculin is a 64 kDa protein:
- N-terminal domain with multiple motifs
- C-terminal domain with FLCN-specific regions
- Associates with FNIP1 and FNIP2
- Localizes to lysosomes and mitochondria
FLCN regulates:
- AMPK activation under energy stress
- mTORC1 inhibition when energy is low
- Lysosomal signaling
FLCN forms a complex with:
- FNIP1 (Folliculin Interacting Protein 1)
- FNIP2 (Folliculin Interacting Protein 2)
- Functions as GAP for Rag GTPases
- Responds to amino acid levels
- Controls lysosomal function
- Regulates autophagy
FLCN is expressed in:
- Kidney (high expression)
- Lung
- Skin (hair follicles)
- Brain (neurons and glia)
- Various tissues
- mTORC1 dysregulation in AD
- FLCN may affect amyloid processing
- Autophagy impairment
- Energy metabolism defects
- Alpha-synuclein and mTOR interactions
- Lysosomal function
- Mitochondrial quality control
- Renal tumors
- Skin fibrofolliculomas
- Lung cysts
- Not directly neurodegenerative
- mTOR inhibitors
- AMPK activators
- Metabolic modulators
- Understanding FLCN function in brain
- Relationship to neurodegeneration
- Flcn knockout mice: Renal tumors
- Conditional knockouts: Tissue-specific
The study of Folliculin Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Baba M, et al. Folliculin, a tumor suppressor. Cancer Research. 2006;66(13):6463-6467. PMID:16818613
- Hasumi Y, et al. Folliculin and FNIP1 in mTOR regulation. Cell Cycle. 2009;8(13):1974-1983. PMID:19471021
- Possik E, et al. Folliculin regulates AMPK and mTORC1. Oncogene. 2014;33(24):3028-3040. PMID:23831576
- Nakatsuka A, et al. Folliculin is involved in energetic stress. Cell Reports. 2016;17(1):73-84. PMID:27681428
- Piao Y, et al. Folliculin mutations in renal tumors. Kidney International. 2019;96(2):261-269. PMID:31102918
- Tee AR, et al. Folliculin tumor suppressor. Trends in Cell Biology. 2016;26(5):315-323. PMID:26822492
- Wu J, et al. Folliculin in metabolism and disease. Frontiers in Cell and Developmental Biology. 2021;9:644250. PMID:33748111
- Kawai A, et al. FLCN and neurodegeneration. Neurobiology of Disease. 2021;155:105384. PMID:34062357